Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Clinical check-in
Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5
The drugs manufacturer reports one in three people on the 10mg or 15mg dose of Zepbound experienced a -25% change in weight in 72 weeks
A weight loss medicines may be considered if: you have a BMI of 30 kg/m 2 or more and have tried various changes for at least 6 months without successful weight loss, or you have a BMI of 27 kg/m 2 or more and have at least 1 weight-related health problem, such as diabetes, pre-diabetes, high blood pressure, high cholesterol, obstructive sleep apnoea or reduced mobility
Call or text: 562.640.8279 Stay hydrated, energized, and revitalized with IVital Health!
